Skip to main content
PMC home page
Blood Cancer Journal logoLink to Blood Cancer Journal
. 2021 Oct 26;11(10):171. doi: 10.1038/s41408-021-00565-6

Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy

Andrew H Wei 1,✉, Panayiotis Panayiotidis 2, Pau Montesinos 3,4, Kamel Laribi 5, Vladimir Ivanov 6, Inho Kim 7, Jan Novak 8, Don A Stevens 9, Walter Fiedler 10, Maria Pagoni 11, Julie Bergeron 12, Stephen B Ting 13, Jing-Zhou Hou 14, Achilles Anagnostopoulos 15, Andrew McDonald 16, Vidhya Murthy 17, Takahiro Yamauchi 18, Jianxiang Wang 19, Brenda Chyla 20, Yan Sun 20, Qi Jiang 20, Wellington Mendes 20, John Hayslip 20, Courtney D DiNardo 21
PMCID: PMC8548337  PMID: 34702803

Correction to: Blood Cancer Journal 10.1038/s41408-021-00555-8, published online 01 October 2021

The title this article was published with was not correct. It should read “6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy”.

Articles from Blood Cancer Journal are provided here courtesy of Nature Publishing Group

RESOURCES